Abstract: A sapphire sheet is laminated to a glass sheet with a gradient layer that transitions from a composition of predominantly Al2O3 at the sapphire sheet to a composition of predominantly SiO2 at the glass sheet. The gradient layer chemically bonds to both the sapphire sheet and the glass sheet and has no distinct interfaces.

Abstract: An interface for positive pressure therapy includes a mask assembly and a headgear assembly. The mask assembly comprises a mask seal that is adapted to underlie the nose. The mask seal extends up the lateral sides of the nose. The mask seal has a primary seal below the nose and a secondary seal alongside the nose.

Abstract: Provided herein are polypeptides that bind to Musk compounds. Also provided are nucleic acid sequences that encode for the polypeptides. Further provided herein is a method for identifying a compound that activates, mimics, blocks, inhibits, modulates, and/or enhances the activity of an olfactory receptor that is activated by a polycyclic Musk or a nitro Musk wherein the receptor is a polypeptide having an amino acid sequence that is at least 75% identical to Olfr96 or OR11A1, wherein the method includes a) contacting the receptor, or a chimera or fragment thereof with a compound and b) determining whether the compound has an effect on the activity of the receptor.

Abstract: An interface for positive pressure therapy includes a mask assembly, a headgear assembly and a connection port assembly. The mask assembly comprises a seal member that has an upper portion movably connected to an integrated lower portion, wherein the upper portion rolls during hinging movement of the upper portion relative to the lower portion. The headgear assembly allows connection to the mask assembly in a direction substantially normal to a direction of strap tension. The connection port assembly includes a swivel elbow with a valve member that controls flow through a port that opens toward the user.

Abstract: Arrangements for controlling a climate control system are provided. A hazard detector of a group of smart devices may detect a carbon monoxide (CO) alarm condition at the hazard detector. The hazard detector may transmit, via a relatively low-power mesh communication network, an indication of the CO alarm condition to one or more other smart devices. A spokesman node of the relatively low-power wireless communication network may translate the indication of the CO alarm condition from a first wireless communication protocol to a second wireless communication protocol. The spokesman node may transmit the indication of the CO alarm condition to a system controller via a relatively high-power wireless communication network and the second wireless communication protocol. A system controller of the climate control system may transmit a signal to turn off at least part of the climate control system.

Abstract: Provided herein are polypeptides that bind to the malodour-causing substance DMTS. Also provided are nucleic acid N sequences that encode for the polypeptides. Further provided herein is a method for identifying a compound that binds, suppresses, blocks, inhibits, and/or modulates the activity of one or more olfactory receptor that is activated by the malodor-causing substance DMTS comprising a) contacting the receptor, or a chimera or fragment thereof with a compound and b) determining whether the compound has an effect on the activity of the receptor. Further provided is an expression vector comprising the nucleic acid encoding the polypeptides described as well as a non-human organism or a host cell modified to express a receptor that is activated by DMTS. Also provided is the use of the polypeptides for identifying malodor modulating compounds.

Abstract: A vehicle charging system includes a charger configured to adjust an output voltage to achieve a voltage request and output a measured output voltage. The vehicle charging system further includes a controller programmed to measure a terminal voltage of a traction battery being charged and receive the measured output voltage from the charger. The controller is further programmed to output the voltage request as a sum of a full charge voltage and an estimated voltage measurement error between the measured output voltage and the terminal voltage.

Abstract: An interface for positive pressure therapy includes a mask assembly, a headgear assembly and a connection port assembly. The mask assembly comprises a seal member that has an upper portion movably connected to an integrated lower portion, wherein the upper portion rolls during hinging movement of the upper portion relative to the lower portion. The headgear assembly allows connection to the mask assembly in a direction substantially normal to a direction of strap tension. The connection port assembly includes a swivel elbow with a valve member that controls flow through a port that opens toward the user.

Abstract: An interface for positive pressure therapy includes a mask assembly, a headgear assembly and a connection port assembly. The mask assembly comprises a seal member that has an upper portion movably connected to an integrated lower portion, wherein the upper portion rolls during hinging movement of the upper portion relative to the lower portion. The headgear assembly allows connection to the mask assembly in a direction substantially normal to a direction of strap tension. The connection port assembly includes a swivel elbow with a valve member that controls flow through a port that opens toward the user.

Abstract: An interface for positive pressure therapy includes a mask assembly, a headgear assembly and a connection port assembly. The mask assembly comprises a seal member that has an upper portion movably connected to an integrated lower portion, wherein the upper portion rolls during hinging movement of the upper portion relative to the lower portion. The headgear assembly allows connection to the mask assembly in a direction substantially normal to a direction of strap tension. The connection port assembly includes a swivel elbow with a valve member that controls flow through a port that opens toward the user.

Abstract: An interface for positive pressure therapy includes a mask assembly, a headgear assembly and a connection port assembly. The mask assembly comprises a seal member that has an upper portion movably connected to an integrated lower portion, wherein the upper portion rolls during hinging movement of the upper portion relative to the lower portion. The headgear assembly allows connection to the mask assembly in a direction substantially normal to a direction of strap tension. The connection port assembly includes a swivel elbow with a valve member that controls flow through a port that opens toward the user.

Abstract: Described herein is a method of using volatile compositions to limit, decrease or eliminate a perception of fecal malodour. Such compositions include a malodour antagonist system associated with perfuming ingredients performing as malodour counteractant, in a combination that significantly reduces the perception of fecal malodour. Such compositions, methods of using the compositions in combination with delivery systems and their applications in consumer products are described herein.

Abstract: Systems and methods are described for interactively, graphically displaying and reporting performance information to a user of an HVAC system controlled by a self-programming network-connected thermostat. The information is made on a remote display device such as a smartphone, tablet computer or other computer, and includes a graphical daily or monthly summary each of several days or months respectively. In response to a user selection of a day, detailed performance information is graphically displayed that can include an indication of HVAC activity on a timeline, the number of hours of HVAC activity, as well as one or more symbols on a timeline indicating setpoint changes, and when a setpoint was changed due to non-occupancy.

Abstract: A patient interface, including a mask assembly and a headgear assembly, provides improved facial sealing and improved ease of use. The mask assembly includes an inflating or ballooning seal. The seal can be secured between two portions of a snap-fit exoskeleton. The headgear assembly connects to the mask assembly with flexible straps during course fitting and with more rigid straps following course fitting. The straps include holes that fit over a tapering post on the mask assembly.

Abstract: An interface for positive pressure therapy includes a mask assembly, a headgear assembly and a connection port assembly. The mask assembly comprises a seal member that has an upper portion movably connected to an integrated lower portion, wherein the upper portion rolls during hinging movement of the upper portion relative to the lower portion. The headgear assembly allows connection to the mask assembly in a direction substantially normal to a direction of strap tension. The connection port assembly includes a swivel elbow with a valve member that controls flow through a port that opens toward the user.

Abstract: A respiratory mask system comprising a mask interface comprising a frame for a headgear assembly. The frame comprises a body comprising a first surface and a substantially opposing second surface. The body further comprises a gas inlet and optionally an outlet vent. The gas inlet may be substantially elliptical in shape. The frame may comprise a recessed region for receiving yoke of a headgear assembly to attach the headgear to the mask interface. The respiratory mask system may also comprise a yoke for attaching to the frame.

Abstract: A patient interface, including a mask assembly and a headgear assembly, provides improved facial sealing and improved ease of use. The mask assembly includes an inflating or ballooning seal. The seal can be secured between two portions of a snap-fit exoskeleton. The headgear assembly connects to the mask assembly with flexible straps during course fitting and with more rigid straps following course fitting. The straps include holes that fit over a tapering post on the mask assembly.

Abstract: A vehicle connected to electric vehicle supply equipment is configured to wake-up an onboard charger based on a pilot signal. A controller is configured to interrupt the pilot signal to prevent the pilot signal from subsequently waking the charger to reduce power consumed by the charger while the vehicle is connected. The interruption may be triggered by a completion of a charge cycle, an extensive charge wait interval, or a charging system condition that prevents charging. The controller may discontinue interruption of the pilot signal in response to a wake-up source other than the pilot signal.